QA: Serina Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001708599_2024_Serina_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001708599, Serina Therapeutics Inc

  xvar xval
0 AssetsCurrent 754,000
1 IntangibleAssetsNetIncludingGoodwill 607,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 10,604,000
4 LiabilitiesCurrent 5,914,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 693,000
7 CostOfGoodsAndServicesSold 39,471
8 SellingGeneralAndAdministrativeExpense 8,942,202
9 ResearchAndDevelopmentExpense 727,193
10 remainder_Expenses 0
11 remainder_Revenues 138,269
12 remainder_NetIncome -5,007,349
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,965,000
1 Liabilities 6,607,000
2 Expenses 9,708,866
3 Revenues 138,269
4 StockholdersEquity 5,358,000
5 NetIncome -14,577,946
6 ComprehensiveNetIncome -14,577,946
7 BaseVar 16,713,242
8 EconomicCapitalRatiobeforeLimitedLiability -0.312
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution

Change over Time